GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of OCUL
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Ocular Therapeutix stock price on Friday which ended trading at $5.22
(Updated on Apr 19, 2024)

Sell candidate since Apr 18, 2024 Loss -10.92% PDF

The Ocular Therapeutix stock price fell by -10.92% on the last day (Friday, 19th Apr 2024) from $5.86 to $5.22. It has now fallen 6 days in a row. During the last trading day the stock fluctuated 18.47% from a day low at $4.98 to a day high of $5.90. The price has fallen in 8 of the last 10 days and is down by -38.15% for this period. Volume has increased on the last day by 3 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 9 million shares were bought and sold for approximately $47.61 million.

Given the current short-term trend, the stock is expected to rise 42.27% during the next 3 months and, with a 90% probability hold a price between $7.43 and $18.37 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

OCUL Signals & Forecast

There are few to no technical positive signals at the moment. The Ocular Therapeutix stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $7.22 and $8.97. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, March 05, 2024, and so far it has fallen -52.24%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Ocular Therapeutix stock

Ocular Therapeutix finds support from accumulated volume at $5.11 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.92 between high and low, or 18.47%. For the last week, the stock has had daily average volatility of 13.26%.

Ocular Therapeutix is oversold on RSI14 (12). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (OCUL) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Ocular Therapeutix to open at $5.37, and during the day (based on 14 day Average True Range), to move between $4.57 and $5.87, which gives a possible trading interval of +/-$0.646 (+/-12.37%) up or down from last closing price. If Ocular Therapeutix takes out the full calculated possible swing range there will be an estimated 24.74% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $5.11 (2.11%) than the resistance at $5.68 (8.81%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Ocular Therapeutix stock A Buy?

The Ocular Therapeutix stock holds several negative signals and despite the positive trend, we believe Ocular Therapeutix will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.313 Sell Candidate Unchanged

Predicted Opening Price for Ocular Therapeutix of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$5.37 ( 2.81%) $5.22

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for OCUL

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 6.29 20.43 %
R2 5.94 13.70 %
R1 5.72 9.54 %
Current price: 5.22
Support S1 5.02 -3.92 %
S2 4.80 -8.08 %
S3 4.45 -14.81 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.88 12.64 %
R2 5.86 12.26 %
R1 5.68 8.81 %
Current price 5.22
Support S1 5.11 -2.11%
S2 4.66 -10.73%
S3 4.07 -22.03%

FAQ

What is the symbol for Ocular Therapeutix Stock and on which exchange is it traded?
The symbol for Ocular Therapeutix is OCUL and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Ocular Therapeutix Stock?
The Ocular Therapeutix stock holds several negative signals and despite the positive trend, we believe Ocular Therapeutix will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Ocular Therapeutix Stock?
Ocular Therapeutix Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Ocular Therapeutix Stock.

What's the current price of Ocular Therapeutix Stock?
As of the end of day on the 2024-04-19, the price of an Ocular Therapeutix (OCUL) share was $5.22.

What is the 52-week high and low for Ocular Therapeutix Stock?
The 52-week high for Ocular Therapeutix Stock is $11.31 and the 52-week low is $2.00.

What is the market capitalization of Ocular Therapeutix Stock?
As of the 2024-04-19, the market capitalization of Ocular Therapeutix is 870.954M.

When is the next earnings date for Ocular Therapeutix?
The upcoming earnings date for Ocular Therapeutix is May 13, 2024.
Click to get the best stock tips daily for free!

About Ocular Therapeutix

Ocular Therapeutix Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cataract surgery; and DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammati... OCUL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT